Article Information
Published By
Online ISSN
History
- Published online March 26, 2020.
Article Versions
- Earlier version (February 11, 2020 - 13:38).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2020 by the American Society of Nephrology
Author Information
- 1Department of Nephrology, Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;
- 2Department of Microbiology, Immunology and Transplantation, Laboratory of Molecular Immunology, Rega Institute, Catholic University of Leuven, Leuven, Belgium; and
- 3Division of Nephrology, University Hospitals Leuven, Leuven, Belgium
- Correspondence:
Dr. Ben Sprangers, Division of Nephrology, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Email: ben.sprangers{at}uzleuven.be
Statistics from Altmetric.com
Article usage
Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor–Associated Acute Kidney Injury: PRO
Jump to section
- Article
- Introduction
- Cases
- ATIN Is the Most Common IRAE but Also Other Kidney Adverse Events Occur in Patients on CPI Therapy
- Not Performing a Biopsy Will Result in an Erroneous Diagnosis in a Significant Subset of Patients
- Current Guidelines Do Not Value Kidney Biopsy Sufficiently
- Histologic Diagnosis Is Necessary to Guide Treatment (or not)
- CPI Retreatment in Patients with Previous Kidney IRAEs
- Discussion of Cases
- Conclusions
- Disclosures
- Author Contributions
- Footnotes
- References
- Figures & Data Supps
- Info & Metrics
- View PDF
More in this TOC Section
Cited By...
- No citing articles found.